Recent Finacing
Recent Raise
P3D manages and coordinates Phase III clinical development programs in the EU, initially supporting label‑expansion trials for an approved therapeutic in partnership with a pharmaceutical company.
Recent Investors
Total Raised
Funding round
Investor